PT Bundamedik Tbk (BMHS.JK)
IDR 246.0
(2.5%)
IDR 246.0
(2.5%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 0.87 IDR | -94.2% |
| 2022 | 14.99 IDR | -59.11% |
| 2021 | 36.66 IDR | 164.31% |
| 2020 | 13.87 IDR | 277.93% |
| 2019 | 3.67 IDR | 511.67% |
| 2018 | 0.60 IDR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 1.00 IDR | 566.67% |
| 2024 Q2 | 0.01 IDR | -98.91% |
| 2024 Q3 | 0.10 IDR | 787.16% |
| 2023 Q3 | 0.23 IDR | 134.85% |
| 2023 FY | - IDR | -94.2% |
| 2023 Q4 | 0.15 IDR | -34.78% |
| 2023 Q2 | -0.66 IDR | -139.05% |
| 2023 Q1 | 1.69 IDR | -29.58% |
| 2022 Q2 | 4.46 IDR | -5.51% |
| 2022 Q1 | 4.72 IDR | 74.81% |
| 2022 FY | - IDR | -59.11% |
| 2022 Q4 | 2.40 IDR | -29.62% |
| 2022 Q3 | 3.41 IDR | -23.54% |
| 2021 Q2 | 8.20 IDR | 9.77% |
| 2021 Q4 | 2.70 IDR | -59.46% |
| 2021 Q3 | 6.66 IDR | -18.78% |
| 2021 Q1 | 7.47 IDR | 186.21% |
| 2021 FY | - IDR | 164.31% |
| 2020 FY | - IDR | 277.93% |
| 2020 Q1 | 0.93 IDR | 0.0% |
| 2020 Q4 | 2.61 IDR | -55.84% |
| 2020 Q3 | 5.91 IDR | 538.23% |
| 2020 Q2 | 0.93 IDR | 0.0% |
| 2019 FY | - IDR | 511.67% |
| 2018 FY | - IDR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| PT Metro Healthcare Indonesia Tbk | -3.34 IDR | 126.048% |
| PT Medikaloka Hermina Tbk | 30.16 IDR | 97.115% |
| PT Mitra Keluarga Karyasehat Tbk | 65.08 IDR | 98.663% |
| PT Murni Sadar Tbk | -6.20 IDR | 114.032% |
| PT Famon Awal Bros Sedaya Tbk | 15.54 IDR | 94.402% |
| PT Royal Prima Tbk | -0.81 IDR | 207.407% |
| PT Kedoya Adyaraya Tbk | 27.09 IDR | 96.788% |
| PT Sarana Meditama Metropolitan Tbk | 0.71 IDR | -22.535% |
| PT Siloam International Hospitals Tbk | 93.27 IDR | 99.067% |
| PT Sejahteraraya Anugrahjaya Tbk | -3.21 IDR | 127.103% |